|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
1995-5-16
|
|
pubmed:abstractText |
To determine whether impaired generation of polyclonal T cell cytolytic activity is over-represented in systemic lupus erythematosus (SLE) compared with other rheumatologic diseases and whether such impaired generation of cytolytic activity waxes and wanes with disease activity and/or changes in medications.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0004-3591
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
38
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
506-16
|
|
pubmed:dateRevised |
2010-3-24
|
|
pubmed:meshHeading |
pubmed-meshheading:7718004-Antigens, CD3,
pubmed-meshheading:7718004-Antirheumatic Agents,
pubmed-meshheading:7718004-Cohort Studies,
pubmed-meshheading:7718004-Humans,
pubmed-meshheading:7718004-Lupus Erythematosus, Systemic,
pubmed-meshheading:7718004-Reference Values,
pubmed-meshheading:7718004-Rheumatic Diseases,
pubmed-meshheading:7718004-Risk Factors,
pubmed-meshheading:7718004-T-Lymphocytes, Cytotoxic
|
|
pubmed:year |
1995
|
|
pubmed:articleTitle |
Impaired polyclonal T cell cytolytic activity. A possible risk factor for systemic lupus erythematosus.
|
|
pubmed:affiliation |
University of Southern California School of Medicine, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|
